Cargando…
The Molecular Mechanisms of Liver Fibrosis and Its Potential Therapy in Application
Liver fibrosis results from repeated and persistent liver damage. It can start with hepatocyte injury and advance to inflammation, which recruits and activates additional liver immune cells, leading to the activation of the hepatic stellate cells (HSCs). It is the primary source of myofibroblasts (M...
Autores principales: | Zhang, Danyan, Zhang, Yaguang, Sun, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604031/ https://www.ncbi.nlm.nih.gov/pubmed/36293428 http://dx.doi.org/10.3390/ijms232012572 |
Ejemplares similares
-
Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
por: Mastroianni, Claudio M., et al.
Publicado: (2014) -
Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
por: Caligiuri, Alessandra, et al.
Publicado: (2021) -
Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
por: Wang, Fa-Da, et al.
Publicado: (2022) -
Small RNA modifications: regulatory molecules and potential applications
por: Xiong, Qunli, et al.
Publicado: (2023) -
Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy
por: Li, Hong, et al.
Publicado: (2022)